Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemia
- 11 September 2000
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 29 (4) , 371-377
- https://doi.org/10.1002/1098-2264(2000)9999:9999<::aid-gcc1050>3.0.co;2-y
Abstract
Despite considerable work on the epigenetic control of tumor suppressor genes, little is known about the potential role of promoter CpG demethylation in the activation of oncogenes in lymphoid tumors. The HOX11 proto‐oncogene is frequently activated in T‐cell acute lymphoblastic leukemia (T‐ALL). HOX11 activation can occur in the absence of translocation of the gene to the T‐cell receptor locus (Salvati et al., 1995 ), implying that activation mechanisms must be involved other than the juxtaposition of the gene to adjacent enhancing sequences. We tested whether the methylation status of the proximal promoter was correlated with expression status in T‐ALL and found that, in all cases, expression of HOX11 in T‐ALL was associated with extensive demethylation of the proximal HOX11 promoter, regardless of whether or not translocation was involved. In contrast, cells that did not express HOX11 showed a more methylated pattern of CpG residues in the proximal promoter. Methylation of this sequence in vitro was sufficient to silence the proximal promoter. We propose a model in which the selection of leukemia clones via a pathway involving HOX11 expression requires the demethylation of its promoter as a prerequisite for additional gene activation mechanisms.Keywords
This publication has 33 references indexed in Scilit:
- A 5′-CG-3′-rich region in the promoter of the transcriptionally frequently silenced RET protooncogene lacks methylated cytidine residuesOncogene, 1998
- Multiple negative elements contribute to repression of the HOX11 proto-oncogeneOncogene, 1998
- Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expressionOncogene, 1998
- Transcriptional Activation of Human LIM-HOX GenehLH-2in Chronic Myelogenous Leukemia Is Due to acis-Acting Effect ofBcr-AblBiochemical and Biophysical Research Communications, 1997
- Alterations in DNA methylation may play a variety of roles in carcinogenesisCell, 1995
- Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotionMolecular Carcinogenesis, 1994
- DNA methylation inhibits transcription indirectly via a methyl-CpG binding proteinPublished by Elsevier ,1991
- Alternative chromatin structure at CpG islandsCell, 1990
- Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumorsToxicology and Applied Pharmacology, 1989
- PER-117: A new human all cell line with an immature thymic phenotypeLeukemia Research, 1987